Clinical Trial Update: StaphVAX Immunogenicity in Orthopedic Implant Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial update reporting immunogenicity data for StaphVAX in patients with orthopedic implants; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prosthetic Joint Infection
• Staphylococcal Infections

Drugs mentioned

• StaphVAX

Snippet

Sponsor: Nabi Biopharmaceuticals | Conditions: Staphylococcal Infections, Joint Prosthesis | Phase 3 | Status: COMPLETED